期刊
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
卷 15, 期 5, 页码 278-285出版社
CIG MEDIA GROUP, LP
DOI: 10.1016/j.clml.2014.12.012
关键词
Cytogenetics; del(17p); Non-Hodgkin lymphoma; Outcomes; Prognosis
资金
- National Institutes of Health [P50CA140158]
- Leukemia and Lymphoma Society
- Harry Mangurian Foundation
- D. Warren Brown Foundation
We evaluated the role of pretreatment cytogenetics in patients with untreated mantle cell lymphoma (MCL). Patients with >= 3 chromosomal abnormalities had inferior progression-free and overall survival and had more high-risk clinical features. The effect of cytogenetics merits further evaluation in prognostic assessment in MCL. Background: Pretreatment cytogenetics are not routinely used to predict patient outcomes in mantle cell lymphoma (MCL). Based on the prognostic utility of cytogenetics in other diseases, we reviewed the effect of a complex karyotype (CK) in MCL. Patients and Methods: We included patients evaluated between November, 2002, and May, 2011. Those with >= 3 chromosomal abnormalities on a pre-treatment cytogenetic evaluation were defined as CK. Demographic, clinical, and survival differences between patients with OK and non-CK (NCK) were assessed. Results: Of 80 patients, 32 (40%) had CK, which was associated with high-risk clinical risk factors. Therapy did not differ between the groups, nor did rate of autologous stem cell transplant (ASCT). The 2-year progression-free survival (PFS) estimates were 70% and 48% for patients with NCK and OK, respectively (P = .02). Two-year overall survival (OS) estimates were also greater in those with NCK versus CK (85% vs. 58%; P = .02). When controlling for high-risk Mantle Cell Lymphoma International Prognostic Index (MIPI) score (P = .006), bulky disease (P = .01), and ASCT in first remission (P = .01), CK was not significantly associated with PFS (P = .18). Conclusion: CK is associated with shortened PFS and OS in MCL but has not been demonstrated to be prognostic independent of other variables in this series. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据